NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000002325

Registered date:11/08/2009

gene profiling study for the efficacy of Trastuzumab

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedbreast cancer
Date of first enrollment2009/06/01
Target sample size60
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary Outcomerepeatability investigation
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. patients with brain metastasis 2. patients with massive effusion 3. patinets with sever heart failure and reduced cardiac function caused treatment with trastuzumab 4. patients with pregnancy

Related Information

Contact

public contact
Name Chikako Shimizu
Address Japan
Telephone
E-mail NCC_IRBoffice@ml.res.ncc.go.jp
Affiliation National Cancer Center breast and medical onoclogy
scientific contact
Name Yasuhiro Fujiwara
Address Tsukiji 5-1-1, Chuo-ku, Tokyo, Japan Japan
Telephone 03-3542-2511
E-mail
Affiliation National Cancer Center breast and medical onoclogy division